John DeSisto

8PUBLICATIONS
48CO-AUTHORS
Gene and molecular therapyMolecular targetsInfant and child healthHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 25, 2025
Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Bethany Veo, Dong Wang, John DeSisto

|May 27, 2025
Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.

Ilango Balakrishnan, Krishna Madhavan, Angela Pierce

|Feb 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial.

Adam L Green, Charles G Minard, Xiaowei Liu

|Feb 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRT.

Irina Alimova, Dong Wang, John DeSisto

|Dec 23, 2024
Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Bethany Veo, Dong Wang, John DeSisto

|Oct 18, 2024
PRMT5 Maintains Tumor Stem Cells to Promote Pediatric High-Grade Glioma Tumorigenesis.

John DeSisto, Ilango Balakrishnan, Aaron J Knox

Pageof 2

Frequent Collaborators

5 joint publications

Rajeev Vibhakar

4 joint publications

Angela Pierce

4 joint publications

Adam L Green

3 joint publications

Sujatha Venkataraman